Skip to main content
OpenTrials

Clinical trial condition

Moderate to Severe Psoriasis

Explore clinical trials studying Moderate to Severe Psoriasis. Study availability and eligibility vary by location and protocol.

7 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Moderate to Severe Psoriasis trial results

Recruiting

Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada

NCT07370766

Conditions
Moderate to Severe Psoriasis, Psoriasis, Psoriasis (PsO), +3 more
Locations
  • Locke Dermatology Hamilton, Ontario, Canada
  • Panorama Dermatology Clinic Kanata, Ontario, Canada
  • Factor Dermatology Ottawa, Ontario, Canada
  • Saskatoon Dermatology Centre Saskatoon, Saskatchewan, Canada
View Trial Details
Completed

Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing

NCT05344248

Conditions
Moderate to Severe Psoriasis
Locations
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Beijing Tsinghua Changgung Hospita Beijing, Beijing Municipality, China
View all 22 locations
View Trial Details
Completed

A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis

NCT03051217

Conditions
Generalized Pustular Psoriasis and Erythrodermic Psoriasis, Moderate to Severe Psoriasis, Psoriasis, +3 more
Locations
  • Ps0017 024 Asahikawa, Japan
  • Ps0017 012 Bunkyō City, Japan
  • Ps0017 010 Chiyoda-Ku, Japan
  • Ps0017 007 Chūōku, Japan
View all 33 locations
View Trial Details
Completed

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

NCT00936065

Conditions
Moderate to Severe Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Pfizer Investigational Site Daejeon, Korea, South Korea
  • Pfizer Investigational Site Gyeonggido, Korea, South Korea
  • Pfizer Investigational Site Seoul, Korea, South Korea
  • Pfizer Investigational Site Seoul, Korea, South Korea
View Trial Details

Related conditions